Connection

Nathan Shapiro to Myxovirus Resistance Proteins

Back to Details
This is a "connection" page, showing publications Nathan Shapiro has written about Myxovirus Resistance Proteins.
Nathan Shapiro
Connection Strength
0.182
Myxovirus Resistance Proteins
  1. A prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever. Ann Med. 2018 08; 50(5):420-429.
    View in: PubMed
    Score: 0.182
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.